About Rob Hopfner
Rob Hopfner is a director and 10% owner at Evommune.
Rob Hopfner reports to the SEC as a director or major shareholder of 5 public companies, including Inozyme Pharma (INZY), Rallybio (RLYB) and Vaxcyte (PCVX).
Rob Hopfner first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Rob Hopfner in the role, so the role may have started earlier or lasted longer.
II
Inozyme Pharma, Inc.
Director and 10% owner
2020 – 2025 · Public company (INZY)
RC
Rallybio Corp
Director
2021 – 2025 · Public company (RLYB)
VI
Vaxcyte, Inc.
Director
2020 – 2021 · Public company (PCVX)
HI
Hyperion Therapeutics Inc.
Director
2012 · Public company (HPTX)
Key Colleagues at Startups
The people Rob Hopfner works with at each company, as listed on that company's latest Form D.
Evommune, Inc. · Form D, Jan 8, 2025
JD
Janice Drew
Executive officer
DC
David Cohen
Director
DD
Derek DiRocco
Director
GM
Gregory Moss
Chief Business and Legal Officer
EB
Eugene Bauer
Executive officer and director
FW
Felice Verduyn-van Weegen
Director
FB
Francois Beaubien
Director
JP
Jeegar Patel
Executive officer
YY
Yuexin Yu
Director
BM
Benjamin McGraw
Director
LP
Luis Pena
Executive officer and director
KC
Kyle Carver
Executive officer